- active not recruitingPHASE3
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
This study looks at a new medicine for adults with overweight or obesity and type 2 diabetes. It aims to see if the medicine helps with weight loss and is safe. The medicine is given as a weekly injection under the skin.
United States · Argentina · Bulgaria - active not recruitingNA
Evaluation of Pharmacist Intervention for Individuals With Uncontrolled Type 2 Diabetes
This study looks at how pharmacists can help people with uncontrolled Type 2 diabetes manage their condition better. It checks if their help improves blood sugar levels and how confident people feel about looking after their diabetes.
Canada - recruitingNA
Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM
This study looks at how high blood sugar and the antibiotic moxifloxacin affect the heart's electrical rhythm in people with type 2 diabetes. Researchers want to see if moxifloxacin's effect on heart rhythm is worse when blood sugar is high or insulin is low, to improve patient safety.
United Kingdom - recruiting
Disentangling the Effect of Brain Insulin Resistance on Brain Health
This study looks into why people with diabetes might have memory and thinking problems. We're exploring if how the brain uses insulin, or damage to brain blood vessels, plays a role. We'll compare people with type 1 and type 2 diabetes with healthy individuals using scans and tests.
Denmark · Germany - recruiting
Ethnic differences in type 2 diabetes pathophysiology
The DIVERSE Study wants to understand how diet helps people with type 2 diabetes differently based on their ethnic background, especially those of Black African, Caribbean, and White European descent. It looks at how a special diet affects blood sugar, weight, and organ fat to improve diabetes care for everyone.
United Kingdom - ongoing, recruitingTherapeutic confirmatory (Phase III)
A single arm study investigating the glycaemic control and safety of adding semaglutide to insulin icodec in participants with type 2 diabetes qualifying for treatment intensification.
This study looks at how well a new combination of medicines, semaglutide and insulin icodec, works for people with type 2 diabetes. It checks if this combination helps control blood sugar levels and if it's safe to use when current treatments aren't enough.
Poland · Czechia